BCR-ABL-IN-9

CAT: 0013-GTR19239805-01Size: 10 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0013-GTR19239805-01Size:10 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

BCR-ABL-IN-9 (Compound B1) is a potent, covalent BCR-ABL kinase inhibitor with an IC50 of 1.2 nM. It achieves sustained target suppression and demonstrates anticancer activity, supporting its use in vitro and in vivo for research on BCR-ABL-driven malignancies like chronic myeloid leukemia.

Field of Research

Cardiovascular Research, Cell Biology, Signal Transduction

Molecular Formula

C22H20N4O3

Molecular Weight

388.42

Storage Conditions

-20°C

Notes

For research use only.

Related Products

Catalog	Name
GTR19206474-01	BCR-ABL-IN-1
GTR19189309	BCR-ABL-IN-3
GTR19239906-01	BCR-ABL-IN-10
GTR19212507-01	BCR-ABL-IN-7
GTR19206473-01	BCR-ABL-IN-2
GTR19249958-01	BCR-ABL-IN-11
GTR19243685-01	BCR-ABL-IN-7
GTR19185202-01	BCR-ABL-IN-6
GTR19184678-01	BCR-ABL-IN-4
GTR19185329-01	BCR-ABL-IN-5

Alternative Products

Catalog	Name
T200990-01	BCR-ABL-IN-9
FP-003	BCR/ABL
PX-P4738-50	BCR-ABL p210 fusion protein (BCR-ABL fusion)
abx376631-01	BCR/ABL P210 Fusion Protein (BCR/ABL) Antibody
BA8807-1	BCR-ABL-IN-8
XKB36918-01	BCR-ABL-IN-2
HY-136526	BCR-ABL-IN-3
T63932-01	BCR-ABL-IN-4
442184-01	Bcr-abl Inhibitor
BUP11553	BCR-ABL-IN-7

BCR-ABL-IN-9

Related Products

Alternative Products

Popular Products